These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22700964)

  • 1. Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease.
    Carta E; Chung SK; James VM; Robinson A; Gill JL; Remy N; Vanbellinghen JF; Drew CJ; Cagdas S; Cameron D; Cowan FM; Del Toro M; Graham GE; Manzur AY; Masri A; Rivera S; Scalais E; Shiang R; Sinclair K; Stuart CA; Tijssen MA; Wise G; Zuberi SM; Harvey K; Pearce BR; Topf M; Thomas RH; Supplisson S; Rees MI; Harvey RJ
    J Biol Chem; 2012 Aug; 287(34):28975-85. PubMed ID: 22700964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel dominant hyperekplexia mutation Y705C alters trafficking and biochemical properties of the presynaptic glycine transporter GlyT2.
    Giménez C; Pérez-Siles G; Martínez-Villarreal J; Arribas-González E; Jiménez E; Núñez E; de Juan-Sanz J; Fernández-Sánchez E; García-Tardón N; Ibáñez I; Romanelli V; Nevado J; James VM; Topf M; Chung SK; Thomas RH; Desviat LR; Aragón C; Zafra F; Rees MI; Lapunzina P; Harvey RJ; López-Corcuera B
    J Biol Chem; 2012 Aug; 287(34):28986-9002. PubMed ID: 22753417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease.
    Rees MI; Harvey K; Pearce BR; Chung SK; Duguid IC; Thomas P; Beatty S; Graham GE; Armstrong L; Shiang R; Abbott KJ; Zuberi SM; Stephenson JB; Owen MJ; Tijssen MA; van den Maagdenberg AM; Smart TG; Supplisson S; Harvey RJ
    Nat Genet; 2006 Jul; 38(7):801-6. PubMed ID: 16751771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLRB is the third major gene of effect in hyperekplexia.
    Chung SK; Bode A; Cushion TD; Thomas RH; Hunt C; Wood SE; Pickrell WO; Drew CJ; Yamashita S; Shiang R; Leiz S; Longardt AC; Raile V; Weschke B; Puri RD; Verma IC; Harvey RJ; Ratnasinghe DD; Parker M; Rittey C; Masri A; Lingappa L; Howell OW; Vanbellinghen JF; Mullins JG; Lynch JW; Rees MI
    Hum Mol Genet; 2013 Mar; 22(5):927-40. PubMed ID: 23184146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperekplexia-associated mutations in the neuronal glycine transporter 2.
    López-Corcuera B; Arribas-González E; Aragón C
    Neurochem Int; 2019 Feb; 123():95-100. PubMed ID: 29859229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations within the human GLYT2 (SLC6A5) gene associated with hyperekplexia.
    Eulenburg V; Becker K; Gomeza J; Schmitt B; Becker CM; Betz H
    Biochem Biophys Res Commun; 2006 Sep; 348(2):400-5. PubMed ID: 16884688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of glycine transporter GlyT2 mutations in startle disease.
    James VM; Gill JL; Topf M; Harvey RJ
    Biol Chem; 2012 Apr; 393(4):283-9. PubMed ID: 22114948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiological mechanisms of dominant and recessive GLRA1 mutations in hyperekplexia.
    Chung SK; Vanbellinghen JF; Mullins JG; Robinson A; Hantke J; Hammond CL; Gilbert DF; Freilinger M; Ryan M; Kruer MC; Masri A; Gurses C; Ferrie C; Harvey K; Shiang R; Christodoulou J; Andermann F; Andermann E; Thomas RH; Harvey RJ; Lynch JW; Rees MI
    J Neurosci; 2010 Jul; 30(28):9612-20. PubMed ID: 20631190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Startle disease in Irish wolfhounds associated with a microdeletion in the glycine transporter GlyT2 gene.
    Gill JL; Capper D; Vanbellinghen JF; Chung SK; Higgins RJ; Rees MI; Shelton GD; Harvey RJ
    Neurobiol Dis; 2011 Jul; 43(1):184-9. PubMed ID: 21420493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of the dominant negative effect of a glycine transporter 2 mutation associated with hyperekplexia.
    Arribas-González E; de Juan-Sanz J; Aragón C; López-Corcuera B
    J Biol Chem; 2015 Jan; 290(4):2150-65. PubMed ID: 25480793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The glycinergic system in human startle disease: a genetic screening approach.
    Davies JS; Chung SK; Thomas RH; Robinson A; Hammond CL; Mullins JG; Carta E; Pearce BR; Harvey K; Harvey RJ; Rees MI
    Front Mol Neurosci; 2010; 3():8. PubMed ID: 20407582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rescue of two trafficking-defective variants of the neuronal glycine transporter GlyT2 associated to hyperekplexia.
    de la Rocha-Muñoz A; Melgarejo E; Aragón C; López-Corcuera B
    Neuropharmacology; 2021 May; 189():108543. PubMed ID: 33794243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-phenotype correlations in hyperekplexia: apnoeas, learning difficulties and speech delay.
    Thomas RH; Chung SK; Wood SE; Cushion TD; Drew CJ; Hammond CL; Vanbellinghen JF; Mullins JG; Rees MI
    Brain; 2013 Oct; 136(Pt 10):3085-95. PubMed ID: 24030948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Role of Dysfunctional Asc-1 Transporter in Distinct Human Pathologies, Human Startle Disease, and Developmental Delay.
    Drehmann P; Milanos S; Schaefer N; Kasaragod VB; Herterich S; Holzbach-Eberle U; Harvey RJ; Villmann C
    eNeuro; 2023 Nov; 10(11):. PubMed ID: 37903619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The P429L loss of function mutation of the human glycine transporter 2 associated with hyperekplexia.
    Kitzenmaier A; Schaefer N; Kasaragod VB; Polster T; Hantschmann R; Schindelin H; Villmann C
    Eur J Neurosci; 2019 Dec; 50(12):3906-3920. PubMed ID: 31370103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel missense mutations in the glycine receptor β subunit gene (GLRB) in startle disease.
    James VM; Bode A; Chung SK; Gill JL; Nielsen M; Cowan FM; Vujic M; Thomas RH; Rees MI; Harvey K; Keramidas A; Topf M; Ginjaar I; Lynch JW; Harvey RJ
    Neurobiol Dis; 2013 Apr; 52():137-49. PubMed ID: 23238346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genetics of hyperekplexia: more than startle!
    Harvey RJ; Topf M; Harvey K; Rees MI
    Trends Genet; 2008 Sep; 24(9):439-47. PubMed ID: 18707791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A glycine transporter SLC6A5 frameshift mutation causes startle disease in Spanish greyhounds.
    Murphy SC; Recio A; de la Fuente C; Guo LT; Shelton GD; Clark LA
    Hum Genet; 2019 May; 138(5):509-513. PubMed ID: 30847549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mutations in
    Dafsari HS; Kawalia A; Sprute R; Karakaya M; Malenica A; Herkenrath P; Nürnberg P; Motameny S; Thiele H; Cirak S
    Cold Spring Harb Mol Case Stud; 2019 Dec; 5(6):. PubMed ID: 31604777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary Hyperekplexia in Saudi Arabia.
    Aldhilan A; Alhakeem A; Al Hajjaj S; Abukhalid M; Aldhalaan H; Salah E; Saeed M; Tabassum S; El Khashab HY; Aljabri M; Ali ES; Alwadei A; Hundallah K; Alghamdi A; Hakami W; AlShafi S; Alkuraya FS; Alanazy N; Seidahmed MZ; Alfadhel M; Tabarki B
    Pediatr Neurol; 2022 Sep; 134():78-82. PubMed ID: 35841715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.